- UroToday Home
- Recent Abstracts
- Urologic Oncology
Bladder Cancer
Follow-up strategies after trimodal treatment for muscle-invasive bladder cancer: a systematic review.
September 23, 2024
HLA-E and NKG2A Mediate Resistance to M. bovis BCG Immunotherapy in Non-Muscle-Invasive Bladder Cancer.
September 23, 2024
APPRAISE-AI Tool for Quantitative Evaluation of AI Studies for Clinical Decision Support.
September 21, 2024
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods.
September 21, 2024
Diagnostic accuracy of cytology and urine methylation test in patients with non-muscle invasive bladder cancer: a systematic review and meta-analysis.
September 20, 2024
Investigating the association between blue light cystoscopy utilization and social determinants of health.
September 20, 2024
Adjuvant immunotherapy in high-risk muscle invasive urothelial carcinoma: A systematic review and meta-analysis of randomized clinical trials.
September 20, 2024
Implementation of Cone Beam Computed Tomography-Guided Online Adaptive Radiotherapy for Challenging Trimodal Therapy in Bladder Preservation: A Report of Two Cases.
September 19, 2024
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.
September 18, 2024
Oncologic outcomes of neoadjuvant chemotherapy and lymph node dissection with partial cystectomy for muscle-invasive bladder cancer.
September 18, 2024
An evaluation of durvalumab across the spectrum of urothelial carcinoma.
September 18, 2024
Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT.
September 18, 2024
"…I Wish Someone Told Me About That…": A Qualitative Assessment of the Educational Needs of Patients Undergoing Cystectomy.
September 17, 2024